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The Editor,
Respiratory problem and ventilation impairment in the 
postcardiac surgery extubation period in the Intensive 
Care Unit (ICU) are frequent. After a successful cardiac 
surgery, plan for patient extubation is necessary, while 
postextubation respiratory management is a challenging 
subject. Postextubation respiratory policy is a method 
to decrease the risk of early respiratory failure and 
reintubation, which is associated with a poor outcome.[1,2] 
Usually, early mobilization, incentive spirometry, respiratory 
physiotherapy, and mucolytic drugs applied in these 
situations. Traditional oxygen therapy by a nasal cannula, 
a simple facial mask or facial mask plus reservoir bag, 
and non‑invasive ventilation including continues or 
bi‑level positive airway pressure are alternative supportive 
methods for ventilation augmentation. There are published 
reports suggest that high‑flow oxygen therapy (HFOT) 
could be a practical strategy in postextubation respiratory 
management.[1‑3]
HFOT is a promising oxygen delivery device that is 
applying a nasal prong, an oxygen blender; a single 
heated circuit, and active humidifier. It acts as a bridge 
between low‑flow oxygen therapies and nasal continuous 
positive airways pressure. At high‑flow oxygen therapy as 
2 L/kg/, applying an appropriate nasal cannula, a positive 
pressure between 4 cm and 8 cm H2O could be achieved. 
Traditional oxygen therapy could deliver up to 16 L/min, 
while HFOT could supply up to 60 L/min, so HFOT has 
gained attention as an innovative method in respiratory 
care for postoperation patients.[1,3] Physicians apply HFOT 
to a variety of patients with different underlying diseases 
such as respiratory failure, exacerbation of chronic 
obstructive pulmonary disease, chronic bronchiectasis, early 
postextubation period, sleep apnea, and heart failure since 
it seems that there have been no big randomized clinical 
trials.[1,4,5] HFOT after planned extubation has been shown 
to help patients mechanically ventilated in the ICU.[1,6] It 
is increasingly used to improve oxygenation because of 
its ease of apply, acceptable, user‑friendly, and clinical 
effectiveness.[1,5,7] We prescribed HFOT in our postcardiac 
surgery patients after extubation in the ICU. It is widely 
accepted that warm (32°C–35°C), humidified constant flow 
provided by HFOT has several preferences, including more 
stable inspiratory oxygen fraction values, anatomical dead 
space elimination, create a reservoir with high fraction 
inspiration of oxygen in the nasal cavity, decrease in work 
of breathing, gas exchange improvement conditioning, 
and a positive physiological effects such as a positive 
end‑expiratory pressure with increased functional residual 
capacity, decreased dyspnea, lower work of breathing, and 
improved cardiovascular parameters.[1,5‑7] Patients in the 
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postoperation period randomly admitted to our open heart 
ICU (there are four ICUs in our educational hospital). 
Each ward has its own responsible and mechanical 
ventilation weaning strategy. Two of them insert HFOT in 
their protocol according to attending physician order. We 
consider 10 patients in each unit for our observation and 
follow‑up. A common protocol for HFOT is the flow rate 
of 2 L/kg/min up to 10 kg body weight and 0.5 L/kg/min 
for each kilogram of patients’ weight. We used a large‑bore 
cannula with the initial flow 10 L/min in the postextubation 
period after cardiac surgery in ICU. The flow meter is 
adjusted to maintain SpO2 in patient’s pulse oximetry 
within target ranges of 92%–98% according to patient 
age, weight, arterial blood gas parameter, and concurrent 
disease.
Based on our observation, the main effective independent 
factor in early reintubation of our postcardiac surgery 
patients after planned extubation in ICU was their 
underlying cardiac problem, but all patients who supported 
by HFOT showed better arterial blood gas parameters 
in comparison with the patient who receives traditional 
respiratory care and support. The patient under HFOT 
showed improvement in oxygenation and CO2 washout as 
well. Early reintubation risk (before 24 h) was the same in 
both groups, but after 24 h of planned extubation, patients 
who received HFOT have the better outcome. Based on 
our observation, the main problem in HFOT prescription 
was patient’s level of consciousness, patient acceptance 
and tolerance, and medical history of sleep apnea besides; 
the common adverse effect of HFOT was trauma to the 
noise, mouth dryness, and gastric distension. Consequently, 
for the patients at risk of early respiratory failure in 
postcardiac surgery period especially in the patient with a 
concurrent respiratory problem who benefit from positive 
end‑expiratory pressure or pressure support, HFOT may 
be a wise acceptable therapeutic policy. However, patients 
who treated with HFOT after cardiac operation need 
extra attention after extubation, to avoid risking delayed 
reintubation.
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